These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 21802414)
1. Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling. Lund IK; Nielsen BS; Almholt K; Rønø B; Hald A; Illemann M; Green KA; Christensen IJ; Rømer J; Lund LR Dev Biol; 2011 Oct; 358(1):56-67. PubMed ID: 21802414 [TBL] [Abstract][Full Text] [Related]
2. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560 [TBL] [Abstract][Full Text] [Related]
3. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers. Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction. Mojsilović SS; Santibanez JF Cell Biol Int; 2015 May; 39(5):619-28. PubMed ID: 25597879 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 controls bone marrow-derived cells therapeutic effect through MMP9 signaling: role in physiological and pathological wound healing. Ebrahimian TG; Squiban C; Roque T; Lugo-Martinez H; Hneino M; Buard V; Gourmelon P; Benderitter M; Milliat F; Tamarat R Stem Cells; 2012 Jul; 30(7):1436-46. PubMed ID: 22570200 [TBL] [Abstract][Full Text] [Related]
6. Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations. Shen Y; Guo Y; Du C; Wilczynska M; Hellström S; Ny T PLoS One; 2012; 7(12):e51303. PubMed ID: 23236466 [TBL] [Abstract][Full Text] [Related]
7. [Effect of vacuum-assisted closure on the expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in acute and chronic wounds healing]. Li YJ; Cao DY; Chen SZ Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Jul; 22(4):306-9. PubMed ID: 17017150 [TBL] [Abstract][Full Text] [Related]
8. Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice. Jögi A; Rønø B; Lund IK; Nielsen BS; Ploug M; Høyer-Hansen G; Rømer J; Lund LR PLoS One; 2010 Sep; 5(9):e12746. PubMed ID: 20856796 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic overlap between MMP-13 and the plasminogen activation system during wound healing in mice. Juncker-Jensen A; Lund LR PLoS One; 2011 Feb; 6(2):e16954. PubMed ID: 21326869 [TBL] [Abstract][Full Text] [Related]
10. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179 [TBL] [Abstract][Full Text] [Related]
11. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653 [TBL] [Abstract][Full Text] [Related]
12. The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice. Kawao N; Tamura Y; Horiuchi Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H PLoS One; 2015; 10(4):e0123982. PubMed ID: 25893677 [TBL] [Abstract][Full Text] [Related]
13. Increased bone formation in mice lacking plasminogen activators. Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826 [TBL] [Abstract][Full Text] [Related]
14. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis. Deindl E; Ziegelhöffer T; Kanse SM; Fernandez B; Neubauer E; Carmeliet P; Preissner KT; Schaper W FASEB J; 2003 Jun; 17(9):1174-6. PubMed ID: 12692088 [TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid. Akinci B; Terzi C; Sevindik G; Yuksel F; Tunc UA; Tunali S; Yesil S J Diabetes Complications; 2014; 28(6):844-9. PubMed ID: 25179235 [TBL] [Abstract][Full Text] [Related]
16. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471 [TBL] [Abstract][Full Text] [Related]
17. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro. Gyetko MR; Aizenberg D; Mayo-Bond L J Leukoc Biol; 2004 Sep; 76(3):648-56. PubMed ID: 15240745 [TBL] [Abstract][Full Text] [Related]
18. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy. Naruse K; Lash GE; Bulmer JN; Innes BA; Otun HA; Searle RF; Robson SC Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641 [TBL] [Abstract][Full Text] [Related]
19. Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis. Menshikov M; Elizarova E; Plakida K; Timofeeva A; Khaspekov G; Beabealashvilli R; Bobik A; Tkachuk V Biochem J; 2002 Nov; 367(Pt 3):833-9. PubMed ID: 12117412 [TBL] [Abstract][Full Text] [Related]